DK1123937T3 - Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf - Google Patents
Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse derafInfo
- Publication number
- DK1123937T3 DK1123937T3 DK99949337T DK99949337T DK1123937T3 DK 1123937 T3 DK1123937 T3 DK 1123937T3 DK 99949337 T DK99949337 T DK 99949337T DK 99949337 T DK99949337 T DK 99949337T DK 1123937 T3 DK1123937 T3 DK 1123937T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- medicine
- substance
- preparation
- chem
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 239000003814 drug Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30263498 | 1998-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1123937T3 true DK1123937T3 (da) | 2004-10-11 |
Family
ID=17911355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99949337T DK1123937T3 (da) | 1998-10-23 | 1999-10-20 | Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6613759B1 (da) |
| EP (1) | EP1123937B1 (da) |
| KR (1) | KR100446323B1 (da) |
| AT (1) | ATE267832T1 (da) |
| AU (1) | AU770166B2 (da) |
| CA (1) | CA2346201C (da) |
| DE (1) | DE69917668T2 (da) |
| DK (1) | DK1123937T3 (da) |
| ES (1) | ES2217815T3 (da) |
| PT (1) | PT1123937E (da) |
| WO (1) | WO2000024747A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1350794B1 (en) * | 2000-12-12 | 2005-06-22 | Sosei Co., Ltd. | Process for preparing substance gm-95 |
| US7045523B2 (en) | 2001-10-18 | 2006-05-16 | Novartis Ag | Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and telomerase inhibitor |
| JPWO2004074295A1 (ja) * | 2003-02-21 | 2006-06-01 | 学校法人慶應義塾 | チアゾール環状多量体、その製造方法、その合成中間体およびその利用 |
| KR20050109958A (ko) * | 2003-03-04 | 2005-11-22 | 가부시키가이샤 소세이 | Ｇｍ-９５ 물질을 함유하는 항종양 효과 증강제, 항종양용조합 제제 및 항종양제 |
| JP2006160723A (ja) * | 2004-11-10 | 2006-06-22 | Marine Biotechnol Inst Co Ltd | 抗腫瘍活性を有する化合物及びその製造方法 |
| DK2087105T3 (da) * | 2006-10-30 | 2015-05-26 | Du Pont | Delta 17-desaturase og anvendelse heraf ved fremstilling af flerumættede fedtsyrer |
| DE102014205356A1 (de) * | 2014-03-21 | 2015-09-24 | Robert Bosch Gmbh | Elektrode für eine Lithium-Zelle |
| CN110283762B (zh) * | 2019-08-01 | 2020-09-22 | 哈尔滨天齐人类第二基因组技术开发应用科技有限责任公司 | 一株具有强力抗癌活性的链霉菌ccpm7649及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1061482B (de) * | 1958-04-29 | 1959-07-16 | R I T Rech Et Ind Therapeutiqu | Verfahren zur Reinigung des Antibiotikums 899 |
| DE3783218T2 (de) | 1986-11-21 | 1993-06-03 | Merck & Co Inc | Fermentationsanaloge von virginiamycin-m1. |
| US5434260A (en) | 1992-10-13 | 1995-07-18 | American Home Products Corporation | Carbamates of rapamycin |
| DE69706950T2 (de) * | 1996-12-18 | 2002-04-25 | Kyowa Hakko Kogyo Co., Ltd. | Furoindolizine |
| JPH11180997A (ja) * | 1997-12-24 | 1999-07-06 | Yamanouchi Pharmaceut Co Ltd | 新規抗腫瘍化合物 |
-
1999
- 1999-10-20 AT AT99949337T patent/ATE267832T1/de not_active IP Right Cessation
- 1999-10-20 DE DE69917668T patent/DE69917668T2/de not_active Expired - Fee Related
- 1999-10-20 US US09/806,475 patent/US6613759B1/en not_active Expired - Fee Related
- 1999-10-20 ES ES99949337T patent/ES2217815T3/es not_active Expired - Lifetime
- 1999-10-20 PT PT99949337T patent/PT1123937E/pt unknown
- 1999-10-20 AU AU62277/99A patent/AU770166B2/en not_active Ceased
- 1999-10-20 CA CA002346201A patent/CA2346201C/en not_active Expired - Fee Related
- 1999-10-20 WO PCT/JP1999/005806 patent/WO2000024747A1/ja active IP Right Grant
- 1999-10-20 KR KR10-2001-7004868A patent/KR100446323B1/ko not_active Expired - Fee Related
- 1999-10-20 DK DK99949337T patent/DK1123937T3/da active
- 1999-10-20 EP EP99949337A patent/EP1123937B1/en not_active Expired - Lifetime
-
2003
- 2003-03-31 US US10/401,589 patent/US7192763B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR100446323B1 (ko) | 2004-08-30 |
| AU6227799A (en) | 2000-05-15 |
| EP1123937A9 (en) | 2001-11-14 |
| WO2000024747A1 (fr) | 2000-05-04 |
| ES2217815T3 (es) | 2004-11-01 |
| US6613759B1 (en) | 2003-09-02 |
| PT1123937E (pt) | 2004-09-30 |
| EP1123937A1 (en) | 2001-08-16 |
| DE69917668T2 (de) | 2005-05-19 |
| ATE267832T1 (de) | 2004-06-15 |
| AU770166B2 (en) | 2004-02-12 |
| CA2346201A1 (en) | 2000-05-04 |
| US7192763B2 (en) | 2007-03-20 |
| EP1123937B1 (en) | 2004-05-26 |
| DE69917668D1 (de) | 2004-07-01 |
| CA2346201C (en) | 2007-06-05 |
| US20030191165A1 (en) | 2003-10-09 |
| KR20010103610A (ko) | 2001-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO893021D0 (no) | Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228. | |
| NZ337861A (en) | N-heterocyclic derivatives for treating multiple sclerosis, HIV dementia, Parkinson's disease, meningitis, atherosclerosis, cancer, inflammatory skin diseases | |
| DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
| SG103194G (en) | Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound | |
| ES555147A0 (es) | Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico | |
| HUT67039A (en) | Process for preparing 2-substituted saccharin derivatives and pharmaceutical compositions containing them | |
| HUT61777A (en) | Process for producing pyrimidine-nukleozides and pharmaceutical compositions containing them as active components | |
| FI95773B (fi) | Menetelmä vesipitoisen, N-(3,4-dimetoksikinnamoyyli)antraniilihappoa sisältävän farmaseuttisen koostumuksen valmistamiseksi | |
| EP0902022A4 (en) | NOVEL BENZOFURANONE DERIVATIVES AND PROCESS FOR THE PRODUCTION THEREOF | |
| PL301576A1 (en) | Novel hiv protease inhibitors, method of obtaining such inhibitors, pharmaceutical preparation and novel initial compounds | |
| NO173444C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater | |
| HUT46536A (en) | Process for producing antianxietive pharmaceutical compositions | |
| DE69011913D1 (de) | Phthalinidderivat, pharmazeutische Zubereitung und Verwendung. | |
| DK1123937T3 (da) | Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf | |
| HUT55034A (en) | Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient | |
| AU7266291A (en) | A novel substituted-amine compound and a process for the preparation thereof | |
| AU695190B2 (en) | Substance FA-70D, process for producing the same, and uses thereof | |
| FR2775976B1 (fr) | Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase | |
| NO20031137D0 (no) | Fremgangsmåte for fremstilling av kirale forbindelser | |
| HUT47020A (en) | Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid | |
| EP0721985A4 (en) | THE SUBSTANCE IT-62-B AND MEDICAL PREPARATIONS CONTAINING IT | |
| BR0109252A (pt) | Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição | |
| MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. |